In this episode, Katie Mihelich and Danielle Jamil provide a redefinition of CRM, and focus in on how it can be used in the rare disorder market space. They'll provide some best practices and key learnings about communicating with the stakeholders in the rare disorder community.
Click here for podcast
Click here for related whitepaper
All PharmaVOICE podcasts
